Skip to main content
Livermore
Livermore
ZHEN

Maravai Lifesciences Holdings, Inc.

MRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001823239

No open-market purchases or sales by Maravai Lifesciences Holdings, Inc. insiders were filed in the last 90 days; 177 institutions reported holding it in 13F filings for Q2 2026, worth $875.5M in total; no superinvestor holds it.

Holders of 5% or more of MRVI

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Maravai Lifesciences Holdings, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MRVI
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A5.90%8.58M shares–Oct 22, 20243 filingsOct 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

49 Schedule 13D and 13G filings on Maravai Lifesciences Holdings, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MRVI
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 13, 20264:30 PM ETFeldman Stuartand 6 others13G/A2.49%3.67M shares−4.57 ppfrom 7.06%Below 5%Jun 30, 2026SEC
Jun 29, 20267:35 PM ETMillennium Management LLCand 2 others13G4.70%6.90M shares−0.26 ppfrom 4.96%Below 5%Jun 23, 2026SEC
Jun 23, 20266:52 PM ETMillennium Management LLCand 2 others13G4.96%7.32M shares+0.06 ppfrom 4.90%Below 5%Jun 16, 2026SEC
May 15, 20268:30 AM ET12 West Capital Management LPand 1 other13G/A4.90%7.26M shares−1.30 ppfrom 6.20%Below 5%Mar 31, 2026SEC
May 14, 20264:22 PM ETFeldman Stuartand 6 others13G/A7.06%10.3M shares+1.56 ppfrom 5.50%Mar 31, 2026SEC
May 12, 20265:33 PM ETMillennium Management LLCand 2 others13G4.90%7.23M shares–Below 5%May 6, 2026SEC
Feb 17, 202610:30 AM ET12 West Capital Management LPand 1 other13G/A6.20%8.92M shares−2.00 ppfrom 8.20%Dec 31, 2025SEC
Feb 13, 20264:26 PM ETFeldman Stuartand 6 others13G/A5.50%7.98M shares−0.67 ppfrom 6.17%Dec 31, 2025SEC
Nov 14, 20259:31 AM ETFeldman Stuartand 6 others13G/A6.17%8.94M shares+1.40 ppfrom 4.77%Sep 30, 2025SEC
Oct 31, 202511:04 AM ETVanguard Group Inc13G/A4.92%7.13M shares−1.59 ppfrom 6.51%Below 5%Sep 30, 2025SEC
Oct 17, 20256:13 PM ETBlackRock, Inc.13G/A5.90%8.58M shares–Sep 30, 2025SEC
Jul 29, 20251:55 PM ETVanguard Group Inc13G/A6.51%9.38M shares–Jun 30, 2025SEC
May 29, 20255:24 PM ETFeldman Stuartand 6 others13G4.77%6.87M sharesNewBelow 5%May 21, 2025SEC
Jan 28, 202511:26 AM ET12 West Capital Management LPand 1 other13G/A8.20%11.6M shares–Dec 31, 2024SEC
Nov 14, 2024Point72 Asset Management, L.P.13G/AOld format–––SEC
Nov 13, 2024Maravai Life Sciences Holdings 2, LLC13G/AOld format–––SEC
Nov 13, 202412 West Capital Management LP13G/AOld format–––SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Oct 29, 2024Millennium Management LLC13G/AOld format–––SEC
Oct 22, 2024BlackRock, Inc.13GOld format–New–SEC
Jun 10, 2024Point72 Asset Management, L.P.13GOld format–New–SEC
May 14, 2024Millennium Management LLC13GOld format–––SEC
Feb 28, 202412 West Capital Management LP13G/AOld format–––SEC
Feb 14, 202412 West Capital Management LP13GOld format–––SEC
Feb 14, 202412 West Capital Management LP13GOld format–New–SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Feb 8, 2024Maravai Life Sciences Holdings 2, LLC13G/AOld format–––SEC
Jan 5, 2024Millennium Management LLC13G/AOld format–––SEC
Nov 7, 2023Massachusetts Financial Services Co13G/AOld format–––SEC
Oct 26, 2023Millennium Management LLC13GOld format–New–SEC
Feb 14, 2023Select Equity Group, L.P.13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 8, 2023Massachusetts Financial Services Co13G/AOld format–––SEC
Nov 10, 2022Select Equity Group, L.P.13G/AOld format–––SEC
Sep 6, 2022Massachusetts Financial Services Co13G/AOld format–––SEC
Sep 6, 2022Massachusetts Financial Services Co13G/AOld format–––SEC
Jul 11, 2022FMR LLC13G/AOld format–––SEC
Feb 14, 2022D1 Capital Partners L.P.SuperinvestorD1 Capital Partners13G/AOld format–––SEC
Feb 14, 2022Select Equity Group, L.P.13G/AOld format–––SEC
Feb 11, 2022Maravai Life Sciences Holdings 2, LLC13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Feb 2, 2022Massachusetts Financial Services Co13GOld format–New–SEC
Nov 9, 2021Select Equity Group, L.P.13GOld format–New–SEC
Apr 12, 2021FMR LLC13G/AOld format–––SEC
Feb 16, 2021D1 Capital Partners L.P.SuperinvestorD1 Capital Partners13GOld format–New–SEC
Feb 11, 2021Maravai Life Sciences Holdings 2, LLC13GOld format–New–SEC
Feb 10, 2021Vanguard Group Inc13GOld format–New–SEC
Feb 8, 2021FMR LLC13GOld format–New–SEC

Form 144: proposed insider sales

2 notices from officers, directors and other affiliates planning to sell Maravai Lifesciences Holdings, Inc. shares, newest first.

Form 144 notices for MRVI
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
May 28, 20248:59 PM ETMaravai Life Sciences Holdings 2, LLCOwner1.53M$16.5MMay 28, 2024Goldman Sachs & Co. LLCSEC
May 28, 20248:58 PM ETMaravai Life Sciences Holdings, LLCOwner8.41M$90.7MMay 28, 2024Goldman Sachs & Co. LLCSEC